Physician profile
Sara Hunter
NPI 1902289028
$66,701.31
in general payments reported to CMS, 2019-2025
83 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $14K · 2023: $11K · 2024: $10K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Consulting Fee: $895 · Education: $322 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,797.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,929.50 |
| Consulting Fee | $895.00 |
| Education | $321.98 |
| Travel and Lodging | $160.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $38,430.49 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,698.35 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Alexion Pharmaceuticals, INC. | $2,498.61 | 2021-2025 | Ultomiris, Soliris |
| Emd Serono, INC. | $2,169.14 | 2021-2025 | Mavenclad, Mavenclad |
| Genzyme Corporation | $2,025.89 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,979.14 | 2021-2025 | |
| Biogen, INC. | $1,133.04 | 2021-2025 | Vumerity, Tysabri |
| Allergan, INC. | $993.34 | 2021-2022 | |
| Sk Life Science, INC. | $877.37 | 2021-2025 | Xcopri |
| Jazz Pharmaceuticals INC. | $793.53 | 2022-2025 | |
| Ucb, INC. | $762.51 | 2021-2025 | Rystiggo, Briviact, Nayzilam |
| Pfizer INC. | $715.12 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $707.96 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $595.70 | 2021-2024 | Spravato |
| Axsome Therapeutics, INC. | $552.51 | 2023-2025 | Symbravo, Sunosi, Auvelity |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $513.24 | 2021-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Sanofi-Aventis U.S. LLC | $443.28 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $429.24 | 2021-2025 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $359.65 | 2023-2025 | Rexulti, Nuedexta |
| Biohaven Pharmaceutical Holding Company LTD. | $330.57 | 2022 | |
| Horizon Therapeutics Plc | $320.72 | 2021-2023 | Uplizna |
| Lilly USA, LLC | $288.30 | 2021-2025 | Kisunla, Amyvid, Emgality |
| Avadel Cns Pharmaceuticals, LLC | $281.61 | 2024-2025 | Lumryz |
| Biohaven Pharmaceuticals, INC. | $270.34 | 2021 | |
| Vanda Pharmaceuticals INC. | $270.34 | 2025 | Ponvory |
| Eisai INC. | $262.85 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $260.75 | 2021-2024 | |
| Lundbeck LLC | $256.72 | 2022-2024 | Vyepti |
| Amgen INC. | $233.11 | 2021-2023 | Aimovig |
| Inspire Medical Systems, INC. | $231.48 | 2023-2025 | Inspire |
| Tg Therapeutics, INC. | $219.74 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $216.25 | 2021-2023 | Andexxa |
| Alkermes, INC. | $187.83 | 2023-2024 | Lybalvi, Vivitrol |
| Sunovion Pharmaceuticals INC. | $181.97 | 2021-2022 | |
| Corcept Therapeutics | $181.72 | 2021-2025 | Korlym |
| Harmony Biosciences LLC | $173.28 | 2022-2024 | Wakix |
| Sumitomo Pharma America, INC. | $173.11 | 2023-2024 | Aptiom |
| Impel Pharmaceuticals INC. | $172.58 | 2022-2023 | Trudhesa |
| Bioventus LLC | $155.32 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Inari Medical, INC. | $151.34 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mdd US Operations, LLC | $139.47 | 2022-2025 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $134.58 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $131.34 | 2021-2025 | Cobenfy |
| Janssen Biotech, INC. | $129.83 | 2025 | |
| Avanir Pharmaceuticals, INC. | $126.15 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $124.99 | 2023 | Quviviq |
| Urovant Sciences INC | $124.99 | 2022 | |
| Argenx US, INC. | $124.56 | 2025 | Vyvgart |
| Bridgebio Pharma, INC. | $124.23 | 2025 | Attruby |
| Madrigal Pharmaceuticals | $124.04 | 2025 | Rezdiffra |
| Stryker Corporation | $116.12 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sage Therapeutics, LLC | $111.92 | 2024 | |
| Aimmune Therapeutics, INC. | $110.74 | 2025 | Zenpep |
| Supernus Pharmaceuticals, INC. | $109.74 | 2021-2022 | |
| Neurelis, INC. | $108.24 | 2021-2024 | Valtoco |
| Amneal Pharmaceuticals LLC | $86.66 | 2022 | |
| Abbott Laboratories | $84.37 | 2021 | |
| Upsher-Smith Laboratories LLC | $76.82 | 2021-2022 | |
| Celgene Corporation | $72.49 | 2025 | Zeposia |
| Phathom Pharmaceuticals, INC. | $71.53 | 2025 | Voquezna |
| Gilead Sciences, INC. | $70.41 | 2021 | |
| Csl Behring | $66.90 | 2024-2025 | Hizentra |
| Lexicon Pharmaceuticals, INC. | $66.08 | 2024 | Inpefa |
| Ultragenyx Pharmaceutical INC. | $60.82 | 2022 | |
| Banner Life Sciences, LLC | $60.62 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.02 | 2025 | Hyqvia, Entyvio |
| Kyowa Kirin, INC. | $55.98 | 2021-2024 | Nourianz |
| Merz Pharmaceuticals, LLC | $52.35 | 2025 | Xeomin, Ampyra, Inbrija |
| Averitas Pharma INC. | $50.29 | 2023 | Qutenza |
| Nevro Corp. | $49.91 | 2021 | |
| Acorda Therapeutics, INC | $45.13 | 2021-2023 | Inbrija, Ampyra |
| Scilex Pharmaceuticals INC. | $45.02 | 2023-2024 | Ztlido |
| Novo Nordisk INC | $44.62 | 2022 | |
| Qol Medical, LLC | $38.18 | 2025 | Sucraid |
| Silk Road Medical, INC. | $37.99 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Merck Sharp & Dohme LLC | $29.32 | 2021 | |
| Avion Pharmaceuticals | $29.19 | 2022-2023 | Dhivy |
| Adamas Pharmaceuticals, INC. | $26.92 | 2021 | |
| Sanofi Pasteur INC. | $22.25 | 2021 | |
| Aucta Pharmaceuticals, INC. | $21.07 | 2025 | Motpoly Xr |
| Xeris Pharmaceuticals, INC. | $15.09 | 2024 | Keveyis |
| Arbor Pharmaceuticals, INC. | $12.22 | 2021 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
Ubrelvy $18KQulipta $12KUltomiris $1,694Austedo Xr $1,341Kesimpta $1,217Zavzpret $696Xywav $615Mavenclad $593Nurtec Odt $566Vraylar $322Botox $311Lumryz $282Lybalvi $274Ponvory $270Ct Thrombectomy System Kit $267Flowtriever Catheter, S $267Leqembi $246Rexulti $237Inspire $231Ocrevus $229Rystiggo $225Austedo $220Vumerity $220Briumvi $220Symbravo $219Xyrem $205Tzield $200Tysabri $183Sunosi $181Aptiom $173Auvelity $153Soliris $151Ingrezza $138Spravato $138Nuplazid $137Vyepti $132Quviviq $125Vyvgart $125Attruby $124Rezdiffra $124Mavyret $124Uplizna $123Nuedexta $123Vivitrol $119Zenpep $111Wakix $110Ocrevus Zunovo $104Kerendia $100Korlym $92.92Enspryng $92.49Epidiolex $90.24Ajovy $87.90Cobenfy $86.37Valtoco $77.75Durolane $77.66Exogen Ultrasound Bone Healing System $77.66Enroute Transcarotid Neuroprotection System $75.98Xcopri $75.42Trudhesa $74.50Zeposia $72.49Voquezna $71.53Vyalev $70.21Mayzent $67.69Hizentra $66.90Inpefa $66.08Andexxa $64.33Briviact $64.19Bafiertam $60.62Qutenza $50.29Nayzilam $47.74Ztlido $45.02Nourianz $44.75Kisunla $39.62Amyvid $39.62Sucraid $38.18Enroute Transcarotid Stent $37.99Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter $37.99Xeomin $37.27Hyqvia $36.19Paxlovid $35.53Comirnaty $35.53Inbrija $32.34Ampyra $32.34Entyvio $21.83Motpoly Xr $21.07Emgality $16.50Reyvow $16.50Dhivy $15.57Keveyis $15.09Aimovig $14.35
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.